| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 03/24/2005 | WO2005012493A3 Anti-cd19 antibodies |
| 03/24/2005 | WO2005011612A3 Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism |
| 03/24/2005 | WO2004108747A3 Lectin conjugates |
| 03/24/2005 | WO2004064869A3 Amyloid-binding, metal-chelating agents |
| 03/24/2005 | WO2004064788A3 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 03/24/2005 | WO2004025270A3 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis |
| 03/24/2005 | WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/24/2005 | US20050063977 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/24/2005 | US20050063967 Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 03/24/2005 | US20050063905 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); polycythemia vera, macroglobulinemia (Waldenstrom syndrome), megakaryocytic myelosis, malignant histiocytosis |
| 03/24/2005 | US20050063904 Method for continuous visualization of a blood clot or plaque in body lumen |
| 03/24/2005 | US20050063903 Combined use of cruciferous indoles and chelators for the treatment of papilloma virus-related conditions |
| 03/24/2005 | US20050063902 Stabiliser for radiopharmaceuticals |
| 03/23/2005 | EP1516185A2 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1404319A4 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 03/23/2005 | CN1599752A Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 03/23/2005 | CN1596985A New clinical parameters for determining haematics toxicity prior to radioimmunotherapy |
| 03/22/2005 | US6870175 Delivery methods, systems and components for use with radiopharmaceutical substances |
| 03/22/2005 | US6869592 Method and antibody for imaging lung cancer |
| 03/22/2005 | US6869590 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 03/22/2005 | US6869589 Cryptate compounds and methods for diagnosis and therapy |
| 03/22/2005 | US6869588 Stimulus sensitive gel with radioisotope and methods of making |
| 03/22/2005 | CA2125189C Pyropheophorbides and their use in photodynamic therapy |
| 03/17/2005 | WO2005023318A1 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b |
| 03/17/2005 | WO2005023317A1 Compounds and kits for preparing imaging agents and methods of imaging |
| 03/17/2005 | WO2005023316A1 A radioisotope-chitosan complex for treatment of prostate cancer |
| 03/17/2005 | WO2005023315A2 Radiolabeled anilinoquinazolines and their use in radioimaging and radiotherapy |
| 03/17/2005 | WO2005023314A1 Compounds containing matrix metalloproteinase substrates and methods of their use |
| 03/17/2005 | WO2005023180A2 Method for detecting cancer cells and monitoring cancer therapy |
| 03/17/2005 | WO2005023177A2 Human monoclonal antibodies against bacillusanthracis protective antigen |
| 03/17/2005 | WO2005023096A2 Methods and compositions for ultrasound imaging of apoptosis |
| 03/17/2005 | WO2004074434A3 Methods and compositions for administering therapeutic and diagnostic agents |
| 03/17/2005 | WO2003101484A9 Compositions and methods for transepithelial molecular transport |
| 03/17/2005 | US20050059118 Hyaluronan receptor for endocytosis |
| 03/17/2005 | US20050059101 Modified bifunctional protein comprising two binding moieties specific to cancer associated antigens for use as tool in tissue targeted therapy of cell proliferative diseases |
| 03/17/2005 | US20050059008 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 03/17/2005 | US20050058839 Immobilization of strontium, elution of rubidium in situ; diagnosis, imaging |
| 03/17/2005 | US20050058638 Biosynthetic binding proteins for immuno-targeting |
| 03/17/2005 | US20050058601 Polypodal chelants for metallopharmaceuticals |
| 03/17/2005 | US20050058599 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 03/17/2005 | CA2538633A1 Radiolabeled anilinoquinazolines and their use in radioimaging and radiotherapy |
| 03/17/2005 | CA2537771A1 Compounds containing matrix metalloproteinase substrates and methods of their use |
| 03/17/2005 | CA2537677A1 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics |
| 03/17/2005 | CA2537493A1 A radioisotope-chitosan complex for treatment of prostate cancer |
| 03/17/2005 | CA2536256A1 Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b |
| 03/17/2005 | CA2535770A1 Method for detecting cancer cells and monitoring cancer therapy |
| 03/17/2005 | CA2526398A1 Human monoclonal antibodies against bacillus anthracis protective antigen |
| 03/16/2005 | EP1514934A2 Biosynthetic binding protein for cancer marker |
| 03/16/2005 | EP1514561A1 Targeting of tumor vasculature using radiolabelled antibody L19 against fibronectin ED-B |
| 03/16/2005 | EP1514105A2 Methods of modulating tubulin deacetylase activity |
| 03/16/2005 | EP1165134B1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers |
| 03/16/2005 | CN1593666A Preparation method of therapy used iodine-125 sealed seed source core |
| 03/16/2005 | CN1593665A Method for preparing radioactive nuclide magnetic microsphere used in vivo |
| 03/16/2005 | CN1593664A Combined guided medicament for treating nasopharyngeal carcinoma and preparation method thereof |
| 03/10/2005 | WO2005021538A1 Novel chelating agents and chelates and their use |
| 03/10/2005 | WO2004110963A3 Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders |
| 03/10/2005 | WO2004082627A3 ENZYME REPLACEMENT THERAPY WITH 17-β-HYDROXYSTEROID DEHYDROGENASE-TYPE 2 |
| 03/10/2005 | WO2004081031A3 Thiol-mediated drug attachment to targeting peptides |
| 03/10/2005 | WO2004003166A3 Antibodies and uses thereof |
| 03/10/2005 | US20050054661 Irritable bowel disorders; anxiolytic agents; antidepressants |
| 03/10/2005 | US20050054007 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 03/10/2005 | US20050053992 Methods for screening cellular proliferation using isotope labels |
| 03/10/2005 | CA2536783A1 Novel chelating agents and chelates and their use |
| 03/10/2005 | CA2529027A1 D-amino acid peptides |
| 03/09/2005 | EP1511721A2 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 03/09/2005 | EP1511518A2 Neutrophil imaging methods in cystic fibrosis |
| 03/09/2005 | EP1511476A2 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 03/09/2005 | EP0869820B1 Cardiovascular and thrombus imaging agents, methods and kits |
| 03/09/2005 | CN1592755A Anti-angiogenic peptides |
| 03/09/2005 | CN1590391A Diphosphonic acid derivative, 99 mTc labelled diphos phonic acid derivative and its application |
| 03/03/2005 | WO2005019247A2 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| 03/03/2005 | WO2005018682A2 Somatostatin analogs with inhibitory activity to growth hormone release |
| 03/03/2005 | WO2005018681A1 Nanoradiopharmaceuticals and methods of use |
| 03/03/2005 | WO2004110151A8 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 03/03/2005 | WO2004073640A3 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 03/03/2005 | US20050049487 Compounds and kits for preparing imaging agents and methods of imaging |
| 03/03/2005 | US20050048000 Amyloid targeting imaging agents and uses thereof |
| 03/03/2005 | US20050047999 Matrix metalloproteinase inhibitors |
| 03/02/2005 | EP1509769A2 Method of screening groups of radioactive molecules and applications thereof |
| 03/02/2005 | EP1509255A1 Methods and compositions for intravesical therapy of bladder cancer |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1586625A Combined article for tumor display and treatment and its preparing method |
| 03/01/2005 | US6861420 N-substituted 1,2,4,5-tetrahydro-1H-benzo[d]azepine compounds |
| 03/01/2005 | US6861044 Radioiodinated sulfonated phenols and process therefore |
| 02/24/2005 | WO2005016888A1 Probe for diseases wth amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 02/24/2005 | WO2005016387A2 Dna-dependent mri contrast agents |
| 02/24/2005 | WO2005016234A2 Compositions, methods, apparatuses, and systems for singlet oxygen delivery |
| 02/24/2005 | WO2004098535A9 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 02/24/2005 | WO2004080335A3 Method for continuous visualization of a body lumen |
| 02/24/2005 | US20050043377 Thioflavin derivatives for use in the antemortem diagnosis of alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 02/24/2005 | CA2500358A1 Probes for diseases in which amyloid accumulates, agents for staining amyloid, drugs for treatment and prophylaxis of diseases with accumulated amyloid, and probes for diagnosis of neurofibrillary tangles and agents for staining neurofibrillary tangles |
| 02/23/2005 | EP1507793A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 02/23/2005 | EP1507562A1 Methods and compositions for radioimmunotherapy of brain and cns tumors |
| 02/23/2005 | EP1507550A1 Suicide tetramers comprising mhc class i and uses thereof |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | CN1585822A Polycistronic expression of antibodies |
| 02/23/2005 | CN1583770A 99m TCN nuclear mark compound, its preparation and application |
| 02/22/2005 | US6858705 Stable radioiodine conjugates and methods for their synthesis |
| 02/22/2005 | US6858633 Substituted 2-arylbenzazole compounds and their use as antitumour agents |